Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1204 of 5804
-
Massive study aims to tame high blood pressure in underserved communities
Disease control Recruiting nowHigh blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and mul…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New DNA test may spot kidney rejection without a needle
Diagnosis Recruiting nowThe goal of this observational study is to learn if the donor-derived cell-free DNA (dd-cfDNA) test can assess rejection in kidney transplant recipients. Participants will have blood and urine collected at their study visit. Researchers will compare results of the GraftAssureDx …
Sponsor: Insight Molecular Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can a 'Love Hormone' spray help schizophrenia symptoms?
Symptom relief Recruiting nowThe effectiveness of current treatment options for sociocognitive deficits and negative symptoms (NS) in schizophrenia spectrum disorders (SSD) remains limited. The cause of NS is thought to be an interference between the mesocorticolimbic dopamine system for social reward expect…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Ancient herbs take on Drug-Resistant lung bug
Disease control Recruiting nowChinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacterium abscessus pulmonary disease (MAB-PD). The investigators aimed to evaluate the efficacy of Chinese herbs as adjunct …
Phase: PHASE2 • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a headset calm anxious teens without pills?
Symptom relief CompletedTrial title: A Randomized, Double-blind Sham-controlled Clinical Trial to Evaluate The Efficacy of Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety in Adolescents - The Modius Calm Adolescent Study The aim of this study: This inv…
Phase: NA • Sponsor: Neurovalens Ltd. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a newer drug prevent spine fractures in acromegaly patients?
Disease control Recruiting nowAcromegaly, a chronic condition characterized by growth hormone (GH) and, in turn, insulin-like growth factor-1 (IGF-I) excess, is burdened by a series of systemic and metabolic comorbidities that strongly impair quality of life (QoL) and life expectancy. Amongst them, a specific…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 26, 2026 18:12 UTC
-
New combo training boosts leg strength and balance in stroke patients
Symptom relief CompletedThis study aims to evaluate the effects of individualized blood flow restriction (BFR) training combined with cognitive-motor dual task intervention on lower limb muscle strength, gait ability, and fall stability in patients with subacute stroke. A total of 28 participants will b…
Phase: NA • Sponsor: Sahmyook University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Experimental 'Drug Vesicles' injected into spine aim to fight lung cancer brain spread
Disease control Recruiting nowThis is a phase I/II, single-arm, open-label, single-center clinical trial to evaluate the safety, tolerability, and preliminary efficacy of intrathecal injection of methotrexate-loaded autologous tumor cell-derived microparticles (MTX-MPs) in patients with leptomeningeal metasta…
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New flu vaccine shows promise in large trial
⭐️ VACCINE ⭐️ OngoingThe present study will evaluate the efficacy, immunogenicity and safety of one dose of OVX836 influenza vaccine 480μg, after intramuscular administration in healthy subjects aged 18-59 years.
Phase: PHASE2 • Sponsor: Osivax • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:04 UTC
-
Light at the end of the tunnel: bright light therapy may boost opioid recovery
Symptom relief Recruiting nowOpioid use disorder (OUD) is a chronic relapsing disorder and is well-known for its high-risk rate of overdoses and death. In OUD, sleep and circadian disruptions are highly prevalent, interfere with opioid maintenance treatment outcomes and increase the risk of relapse. So far, …
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Could a simple scan replace kidney biopsies? new study tests a tracer that sees scarring
Diagnosis Recruiting nowInterstitial fibrosis is a hallmark of progression in chronic kidney disease (CKD), yet it can presently be assessed only by kidney biopsy, which is invasive and prone to sampling error. In recent years the advances in molecular imaging, especially high spatial and temporal reso…
Phase: NA • Sponsor: Medical University of Vienna • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail aims to fight advanced skin cancer
Disease control Recruiting nowThis study is an open-label, multicenter phase Ib/II study to evaluate the efficacy and safety of LBL-024 monotherapy, LBL-024 in combination with LBL-007 or toripalimab in patients with advanced melanoma,To evaluate the preliminary efficacy and safety of LBL-024 monotherapy and …
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail targets Hard-to-Treat stomach cancer
Disease control Recruiting nowThis is a multicenter, phase 2, open label study to evaluate safety, tolerability and efficacy of SHR2554 combined with other anti-tumor treatments in patients with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:42 UTC
-
New hope for lymphoma patients: drug combo shows promise in early trial
Disease control Recruiting nowThis is a single-arm, open-label, multicenter, non-indication seeking phase II trial to describe the efficacy and safety of patients with mantle cell lymphoma (MCL) receiving acalabrutinib in combination with R-CHOP for the front-line treatment of MCL in Spain. Acalabrutinib wil…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New study aims to keep kids Malaria-Free after hospital stays
Disease control Recruiting nowThe goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with dihydroartemisinin-piperaquine in the post-discharge management of children hospitalised with severe anaemia or severe malaria …
Phase: PHASE4 • Sponsor: Liverpool School of Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New stool test aims to catch colorectal cancer early in thousands
Diagnosis Recruiting nowThe post-approval study (PAS) described here will supplement existing data generated in the CRC-PREVENT clinical trial. The primary outcomes of this supplemental study will include: clinical sensitivity, clinical specificity, positive predictive value (PPV), and negative predicti…
Sponsor: Geneoscopy, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Shocking new hope: brain zaps and tablet games may rewire stroke-damaged arms
Symptom relief Recruiting nowStroke is one of the leading causes of long-term disability worldwide. Many individuals who survive a stroke continue to experience weakness and reduced control of one arm, even months or years after the event. These motor impairments significantly affect independence, daily acti…
Phase: NA • Sponsor: School of Health Sciences Geneva • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could a smart sensor replace the sleep lab? new study tests AI-Powered home screening for sleep apnea
Diagnosis Recruiting nowThis study aims to develop a multimodal deep learning model that integrates noninvasive signals to predict the severity of obstructive sleep apnea. By establishing a clinically viable and user-friendly monitoring tool, the study seeks to enhance early screening accessibility and …
Sponsor: Fu Jen Catholic University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Robotic surgery gets a sense of touch: could force feedback speed lung recovery?
Disease control Recruiting nowThe purpose of this research is to study patient outcomes based on the use of Force Feedback instruments during robotic-assisted lung resection. Force Feedback technology describes the physical forces a surgeon senses when pushing and pulling structures inside the body during rob…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for lung cancer patients who failed targeted treatment?
Disease control Not yet recruitingAK112 in non-squamous non-small cell lung cancer patients with actionable genomic alterations (AGA) who have failed to previous tyrosine kinase inhibitor (TKI) treatment
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 26, 2026 14:32 UTC